SMS Pharmaceuticals Q3FY21 consolidated PAT up to Rs. 21.39 Cr
News

SMS Pharmaceuticals Q3FY21 consolidated PAT up to Rs. 21.39 Cr

The company posted net profit of Rs.7.61 crores for the period ended December 31, 2019.

  • By IPP Bureau | February 11, 2021

SMS Pharmaceuticals has reported total income of Rs.149.72 crores during the period ended December 31, 2020 as compared to Rs.131.04 crores during the period ended September 30, 2020.

 

The company reported total Rs.81.24 crores during the period ended December 31, 2019.

 

SMS Pharmaceuticals has posted net profit of Rs.21.39 crores for the period ended December 31, 2020 as against net profit of Rs.10.96 crores for the period ended September 30, 2020.

 

The company posted net profit of Rs.7.61 crores for the period ended December 31, 2019.

 

For the 9 months period ended December 31, 2020, SMS Pharmaceuticals has reported total income of Rs.394.04 crores as compared to Rs.317.50 crores during the 9 months period ended December 31, 2019.

 

The company has posted net profit of Rs.39.38 crores for the 9 months period ended December 31, 2020 as against net profit of Rs.25.18 crores for the 9 months period ended December 31, 2019.

 

The company has reported EPS of Rs.4.65 for the 9 months period ended December 31, 2020 as compared to Rs.2.97 for the 9 months period ended December 31, 2019.

Upcoming E-conference

Other Related stories

Startup

Digitization